Julia Coronado
Latest Stories (30)
Halfway through 2013, how's the economy doing?
Jul 1, 2013
With 2013 halfway done, how is the economy doing? Julia Coronado, chief North American economist BNP Paribas, shares her take.
F, E, D, spells what for stimulus policy?
Jun 17, 2013
As uncertainty over the Federal Reserve's stimulus policy continues, financial markets prolong their bumpy ride.
Unemployment ticks up to 7.6%, 175,000 jobs added
Jun 7, 2013
The Bureau of Labor Statistics reports that the economy added 175,000 jobs last month, edging out analyst expectations. The unemployment rate ticked up to 7.6 percent.
Is the economy ready to fly by itself?
May 20, 2013
What happens if the Federal Reserve takes away the big can of sterno it put under the U.S. economy?
Retail sales edge up in April
May 13, 2013
Did you buy a car or get some new clothes recently? You were not alone.
Jobs are one thing, but what about credit?
May 6, 2013
One way to evaluate the health of an economy is to look at the jobs picture, which looks pretty rosy so far this spring. But there’s another sign to keep any eye on: the availability of credit.
Signs of weakness in how much we make and how much we spend
Apr 29, 2013
U.S. personal income and consumer spending increased by 0.2 percent in March. Julia Coronado, chief economist with the investment bank BNP Paribas, discusses the numbers and what they mean for the economy.
Markets hit by uncertainty of French election
Apr 23, 2012
European markets are down significantly, and that's being blamed on elections over the weekend in France that increase the likelihood that Conservative President Nicholas Sarkozy will lose his job.
March jobs report disappointing, but not a disaster
Apr 9, 2012
After news that Sony is cutting 6 percent of its workforce and that the U.S. economy only added 120,000 jobs last month, the future doesn't look bright -- but a bigger picture shows it's all just part of a slow recovery.
Is this the beginning of merger season?
Apr 2, 2012
The beauty and fragrance company Coty went public with its offer to buy rival Avon for about $10 billion -- that's an offer Avon so far has rejected. And Express Scripts and Medco -- two companies that process prescriptions at the drug store -- have gotten federal approval for their merger.